Isolated Hepatic Perfusion for the Treatment of Patients With Colorectal Cancer Liver Metastases After Irinotecan-Based Therapy
- 4 February 2005
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 12 (2) , 138-144
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III TrialJournal of Clinical Oncology, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Hepatic-arterial chemotherapyThe Lancet Oncology, 2001
- Phase I Study of Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic Irinotecan for Unresectable Hepatic Metastases From Colorectal CancerJournal of Clinical Oncology, 2001
- Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancerSurgery, 2001
- Technique and Results of Hyperthermic Isolated Hepatic Perfusion with Tumor Necrosis Factor and Melphalan for The Treatment of Unresectable Hepatic MalignanciesJournal of the American College of Surgeons, 2000
- Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2000
- Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerJournal of Clinical Oncology, 2000
- Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialThe Lancet, 2000
- First experience and technical aspects of isolated liver perfusion for extensive liver metastasisSurgery, 1998